Patent directory · USPTO A61K / A61P
Browse patents
Browse 30,257 pharma-relevant patents (US A61K/A61P) linked to tracked companies, drugs, and pipeline programs.
Quick answer
NovaPharmaNews indexes 30,257 US pharmaceutical patents from USPTO PatentsView (CPC A61K/A61P), cross-linked to company assignees, drug INN profiles, and pipeline programs. Search by patent number, applicant, title, or CPC code — or use facet hubs for expiring patents, assignees, and therapeutic areas.
Patent results
-
US 12371414
Methods of treating neurological disorders
granted -
US 12371466
Chimeric antigen receptor and methods of use thereof
granted -
US 12371420
Polymorphs of Selinexor
granted -
US 12370270
Methods for distributing high levels of therapeutic agent throughout the cortex to treat neurological disorders
granted -
US 12371499
Method of treating cancer using anti-AV8 antibodies
granted -
US 12370245
ALK polypeptides and methods of use thereof
granted -
US 12370267
Inhibition of fibrosis and AF by TGF-beta inhibition in the posterior left atrium (PLA)
granted -
US 12370255
Peptide-based vaccines, methods of manufacturing, and uses thereof for inducing an immune response
granted -
US 12371445
Heteroaromatic silicon-fluoride-acceptors useful for 18F labeling of molecules and biomolecules, and methods of preparing same
granted -
US 12370261
Chimeric peptides for antisense delivery
granted -
US 12370142
Manufacturing of bupivacaine multivesicular liposomes
granted -
US 12370266
Polymer composite nanomaterial encapsulation system
granted -
US 12370229
Methods of treating bladder cancer
granted -
US 12370196
Pharmaceutical compositions comprising meloxicam
granted -
US 12370206
Therapy for inhibition of single-stranded RNA virus replication
granted -
US 12370232
Use of polyphenol containing sugar cane extracts for preventing, improving or treating a skin condition
granted -
US 12371685
PH20 polypeptide variants with a modification at position 324 of the PH20 polypeptide and a method of making thereof
granted -
US 12370194
Metalloenzyme inhibitor compounds
granted -
US 12370195
Oral compositions of MK2 pathway inhibitor for treatment of immune conditions
granted -
US 12370257
Materials and methods of treating MHC-I-opathy risk haplotypes
granted -
US 12371665
Differentiation of pancreatic endocrine cells
granted -
US 12370256
Activation of resident memory T cells for the treatment of cancer
granted -
US 12370175
Glucocorticoid receptor modulators to treat pancreatic cancer
granted -
US 12370188
Formulations of dazucorilant, a glucocorticoid receptor modulator
granted
Frequently asked questions
What patents are included in this directory?
We index 30,257 published US pharma-relevant patents filtered to CPC classes A61K and A61P, with assignee links to our company directory where a match exists.
How do I search for a patent?
Use the search box to match patent number, title, applicant name, or CPC classification (e.g. A61K). For cross-entity queries spanning news and drugs, use the global search.
How is this different from the patent intelligence dashboard?
The dashboard at /patents highlights expirations, recent grants, and assignee rankings. Browse is the full paginated directory with search — best for looking up a specific filing or applicant portfolio slice.